Insmed
+$1.57 (+7.91%) Today
$0.00 (0.00%) As of 9:42 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Insmed and other ETFs, options, and stocks.
About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
CEO
William H. Lewis
Employees
613
Headquarters
Bridgewater, New Jersey
Founded
1988
INSM Key Statistics
Market cap
2.56B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.26M
High today
$21.50
Low today
$19.89
Open price
$20.10
Volume
2.17M
52 Week high
$34.44
52 Week low
$16.41
INSM News
Analyst ratings
100%
of 11 ratings
Buy
100%
Hold
0%
Sell
0%
INSM Earnings
-$1.00
-$0.67
-$0.33
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market